Mutations in the vitamin D receptor gene in three kindreds associated with hereditary vitamin D resistant rickets

F J Cockerill1, N S Hawa, N Yousaf

  • 1Department of Medicine, University College London Medical School, Middlesex Hospital, United Kingdom.

Insights

Genetic mutations in the vitamin D receptor (VDR) gene cause hereditary vitamin D resistant rickets. Our study identified specific VDR mutations, including STOP codons and deletions, explaining this rare genetic disorder.

Area of Science:

  • Genetics
  • Endocrinology
  • Molecular Biology

Background:

  • Hereditary vitamin D resistant rickets is linked to mutations in the vitamin D receptor (VDR) gene.
  • These mutations affect critical domains of the VDR, including DNA and ligand binding sites.

Purpose of the Study:

  • To identify and characterize the specific mutations in the VDR gene responsible for hereditary vitamin D resistant rickets in three families.
  • To confirm the functional impact of these identified mutations on VDR activity.

Main Methods:

  • Cultured skin fibroblasts were used to assess resistance to 1,25(OH)2D3 and 24-hydroxylase activity.
  • DNA sequencing of the VDR gene coding region was performed to detect mutations.
  • Transactivation studies and gel shift assays were employed to evaluate the functional consequences of the mutations.

Main Results:

  • Patients 1 and 2 had undetectable 1,25(OH)2D3 binding to VDR due to a STOP codon mutation and a frameshift deletion, respectively.
  • Patients 3 and 4, siblings, exhibited a point mutation in the VDR hormone-binding domain, affecting protein interactions.
  • Functional studies confirmed that all identified mutations impaired VDR activity.

Conclusions:

  • Specific mutations in the vitamin D receptor (VDR) gene, including premature termination and hormone-binding domain alterations, cause hereditary vitamin D resistant rickets.
  • These genetic defects disrupt VDR function, leading to impaired response to vitamin D and the associated clinical condition.

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...